Skills this job asks for
PharmacyPatient careComplianceTranslationProduct managementLeadership
Add your CV (free) to see which of these your CV is missing.
Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 40 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 40 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
ROLE SUMMARY
The Vice President, Vaccines Sales is a senior commercial leader responsible for driving portfolio performance across the United States. As a key member of the Primary Care CEP Team and the U.S. Vaccines LT, this leader sets and executes an integrated national sales strategy to meet or exceed sales goals for promoted vaccines and prepare for the launch of new products. The VP holds direct oversight of four Regional Business Directors (RBDs), an Operations Team Lead, and an Enablement Lead, and partners with the Vaccines Accounts, Retail Pharmacy, and U.S. Marketing teams. This role serves as the primary brand interface for Prevnar 20, Abrysvo, Comirnaty, and the Meningococcal franchise, and is a critical bridge between today's portfolio and anticipated vaccine launches. The reach of this multi-channel organization spans HCPs, hospitals, government agencies, accounts, pharmacies, patient care centers, and other institutional customers nationwide. This leader sets a compelling vision, inspires action, develops their team, and demonstrates agility, business acumen, and an uncompromising commitment to Pfizer's Values and compliance, enabling recommended immunizations that protect people at all stages of life.
KEY DIMENSIONS
Reports To
CEP Lead, U.S. Primary Care President
Direct Reports
4 Regional Business Directors; Enablement Lead; Operations Team Lead
Indirect Reports
Vaccines Portfolio ABMs and field representatives across the U.S.
Budgetary Impact
Significant revenue responsibility across Prevnar 20, Abrysvo, Comirnaty, and the Meningococcal franchise; accountable for the national Vaccines performance scorecard
Travel
National, estimated 40%; field presence in markets and travel to HQ as necessary
ROLE RESPONSIBILITIES
Portfolio Performance
• Deliver net revenue results across the full Vaccines portfolio for the U.S.: Prevnar 20 Adult and Pediatric, Abrysvo Adult and Maternal, Comirnaty 12+, and the Meningococcal franchise.
• Develop and execute national sales strategies and goals informed by and aligned with U.S. Marketing team goals and tactics.
• Work directly with the Marketing and Access teams to develop and execute brand strategies, brand prioritization, and contracting.
• Manage expense base and resource allocation with discipline; build business cases for differential investment against highest-impact opportunities.
• Monitor and ensure executional excellence across the multi-franchise Vaccines portfolio.
• Provide tailored, channel-appropriate direction, objectives, and coaching to Sales Leaders.
• Identify short-, mid-, and long-term sources of business opportunity and track against a cross-functional implementation plan.
• Optimize promotional spend, budget, and workload across the team to maximize ROI.
• Set challenging goals and track defined performance metrics.
• Lead seasonal demand planning and field readiness across immunization seasons, partnering with Marketing, Access, Accounts, and Retail Pharmacy to align execution and timing.
• Interpret and respond to shifts in immunization recommendations, policy, and access (e.g., ACIP, payer, and state pharmacy policy), translating them into field strategy and execution.
Ownership of National Vaccines Enterprise
• Act as the single owner of the national Vaccines sales organization, driving one consistent execution model across all regions.
• Develop and maintain an Incentive Compensation program that aligns to the BU and brand operating plans while motivating each member of the sales team.
• Represent Vaccines as a member of the U.S. Sales Council.
• Partner with the CEP Lead on national CEP strategy decisions, including training, POA planning, and ABM/rep expectation-setting.
• Own brand relationships at the VP level, representing the
Apply on employer site ↗